between the parameters of Body Part "X" Malignant Lesion Density vs. Time Period of Medical Therapy with an integrated smart infusion pump system.
At point q1 the medical therapy begins with the use of a smart infusion system.
At point q2 during the continuation of the medical therapy the patient's prognosis is that of a receding density of lesions as determined by way of imagery scans and blood works, as well as general disposition of the patient.
From points p to s diagnostics tests are done at times q3 and q4 and the patient's condition seems to have stabilized. So slightly before time s onwards, the wrong or right decisions may be :
Wrong Decision : Medical Therapy is terminated or substituted with a less effective type before or at time s. Consequently tests at points q5a and q5b indicate a condition of increasing lesion density and the patient eventually passes on.
Right Decision : Medical therapy continues or is substituted with a more effective type. Consequently tests at point q6a and q6b return the prognosis of an improving patient, to the point of healing or maximum possible sustained suppression of the disease. This would allow for much lower and sustained dosages to be introduced in the long run to ensure there is no major recurrence of the lesions. Smart infusion
systems are yet to be equipped with sufficient levels of Artificial Intelligence for them to read and understand the curve in GRAPH 1.
A smart infusion system would not detect the molecular oncology implications of its functions, e.g. biopsy or scan results. It is currently smart only to the extent that it would administer the correct therapy, at the correct dose at the correct rate and time, to the correct patient, if it is well managed. But at no time would it perform complex and independent analysis of the patient and demand/request for more information or make a medical decision or provide decision support thereafter.
A broad spectrum of Artificial Intelligence Systems would be required to make smart infusion pump systems, practically smart e.g. Machine Learning to assess blood works results, image processing to deduce lesion density from imaging scans, case based systems to call for more tests or to render decisions . Lesion density could be determined by taking non-intrusive internal imagery scans from different angles and evaluating colour contrast. Alarm fatigue may occur due to frequent unintended alarms as a result of poor calibration of drug library limits, the consequence to patient safety would be that nursing staff may become tired of reviewing alerts, enhancing the risk of a critical alert being overlooked and a patient being harmed during parenteral therapy.
Human-on-the-Loop functionality in responding to smart infusion pump alerts is a major safety provision in these systems. But this can only prevent Recessive Lethal
Autonomy to the extent that the Drug Library limits are correct and the computer source code for the DERS/MERS engine that is reading the limits and actuating the pump functions has no errors.
A casual check on the Internet at the time of research for this analytic paper The complexity of networked control/computing systems and smart infusion systems may introduce new unknown types of malfunctions and medical errors. Probably the most lethal possible error shall be by way of some recessive in-built system fault at microscopic/nanoscopic or coding levels, one that is not known to the infusion pump operators and manufacturers. There are unlikely to be any set training schemes and procedures for handling unknown situations. Recessive problems can only be discovered by the system operators as they occur and adversely affect patient safety.
Other problems could be of unintended systems architecture type e.g. the use of radio-frequency identity tags instead of bar-codes, in the switch key function for activating a smart infusion pump via providing clinician identity and patient identity details. This is due to the possible but inadvertent accident sending data from radiofrequency identity tags to a wrong smart infusion pump nearby in the range of reception, something that Trbovich et al [11: 18] A notable challenge is that Mansfield and Jarrett, 2015 was an intra-organzational study work, unless its publication is responded to by the relevant practitioners there is no indication of its immediate adoption.
As smart infusion pumps function they generate alerts/alarms, functions, conditions and responses data, these are also known as Continuous Quality Improvement (CQI) data (Jog et al, 2015)
Examples of Intravenous Medication Administration Recursive Concurrence

Protocols for Addressing Recessive Lethal Autonomy
Reduction of the probability for occurrence of errors or undetected malfunctions, can be achieved by introducing technically sound and clinically feasible practices that diminish the likelihood of problematic events. For example on keypad entries into the smart infusion system, the likelihood of erroneous entries can be limited by ways of concurrence i.e. a requirement that two people enter data before it is accepted by the system. e.g. probability of one error/malfunction occurring if Operator X uses the keypad of the smart infusion pump or checks alerts/alarms N(x) times is 1/N(x) Record obtained by remote-query by a smart infusion pump, there would be questions in the "World of Informatics" as to the smartness of the system. Artificial
Intelligence would also scan Continuous Quality Improvement data during an intravenous infusion as well as sensor data, to render decisions and/or decision support.
Despite the assessments [8] the absence of clinically significant alerts during parenteral therapy with a smart infusion pump, may not necessarily translate to the absence of occurrences/events with clinically significant adverse effects for a patient after a procedure, e.g. failure to recover from anesthesia or any wrong combination of medications that go undetected.
The [7] The researcher who composed this analytic paper did not find any literature on the convergence of the two projects to date, an occurrence that would be beneficial to the wider Medical Informatics Community.
The Purdue Study [6] 
Conclusion
Artificial Intelligence, Big Data Analytics, Concurrence Protocols, Counter-chronic performance problems protocols, etc. would reduce possible patient harm, in the course of medication administration with use of smart infusion pumps.
